相关实验视频
Updated: Feb 14, 2026
08:23
Assessing Burrowing, Nest Construction, and Hoarding in Mice
Published on: January 5, 2012
33.2K
评估Hurley I型状腺炎supurativa患者的疾病进展:一个嵌套病例控制研究
Dermatology (Basel, Switzerland)
|February 12, 2026
概括
这项研究确定了诸如吸烟和疾病严重程度等因素,这些因素可以预测从Hurley I阶段到更严重的形式的Hidradenitis Supurativa (HS) 患者的进展. 了解这些因素可以帮助识别有风险的个人进行早期干预.
科学领域:
- 皮肤病学 皮肤病学
- 炎症性皮肤疾病是一种炎症性皮肤疾病.
- 慢性病的进展 慢性病的进展
背景情况:
- 补腺炎 (HS) 是一种慢性炎症性皮肤疾病,其特点是逐渐的结构变化,通常使用Hurley系统分阶段.
- 早期的Hurley I患者可能会进展到更严重的形式 (Hurley II-III),但这种进展的发生率和驱动因素尚不清楚.
研究的目的:
- 在HS患者中确定从Hurley I阶段到Hurley II和III阶段的进展的发生率.
- 确定与HS结构性进展相关的临床特征,患者习惯和干预措施.
主要方法:
- 对133名Hurley I HS患者进行了一项回顾性队列研究.
- 一项嵌套病例控制研究通过临床和超声波评估确定了与进展相关的因素.
- 进行了单变量和多变量分析来评估关联.
主要成果:
- 在随访期间,累计进展到Hurley II或III的发病率为37.6% (50/133名患者).
- 进展的重要独立预测因素包括更高的每日吸烟量,Hurley Ic阶段和瘤数量的增加.
- 腹排水增加与进展风险降低有关.
结论:
- 临床特征,吸烟状况和治疗变量可以帮助识别HS患者的疾病进展风险较高.
- 需要对更大的队列进行进一步的研究,以验证这些预测性因子对hidradenitis suppurativa的有效性.
相关概念视频
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.2K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
475
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
475
02:07Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
164
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
164
01:24Nursing Process for Patient and Caregiver Teaching I: Assessment and Diagnosis
2.5K
The nursing process provides a clinical decision-making framework for patients and families to establish and implement a personalized care plan. Since part of the nurse's duties is to teach patients, the steps of the nursing process are the most effective way to approach instruction. The nursing process and the teaching-learning process are inextricably linked.
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
It is critical to determine the patient's learning needs during the assessment. Determination of learning needs compounds data...
2.5K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K